| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Duffy SP, Criner GJ. Chronic obstructive pulmonary disease: Evaluation and management[J]. Med Clin North Am, 2019, 103(3): 453-461.
|
| 3 |
梁振宇，陈荣昌. 慢性阻塞性肺疾病诊疗指南(2021年修订版)修订历程及思考[J]. 中华结核和呼吸杂志，2021, 44(3): 165-166.
|
| 4 |
孙永昌. 慢性阻塞性肺疾病在中国基层医疗机构面临的挑战和应对[J]. 中华结核和呼吸杂志，2020, 43(1): 14-16.
|
| 5 |
Agnihotri NT, Saltoun C. Acute severe asthma (status asthmaticus)[J]. Allergy Asthma Proc, 2019, 40(6): 406-409.
|
| 6 |
Van der Poorten T, De Hert M. Sublingual use of atropine for clozapine-induced sialorrhoea: literature review and two case reports[J]. Tijdschr Psychiatr, 2019, 61(6): 403-410.
|
| 7 |
姚香萍. 布地奈德联合异丙托溴铵治疗慢性阻塞性肺疾病的临床研究[J]. 现代药物与临床，2019, 34(10): 2985-2989.
|
| 8 |
Arif E, Nihalani D. Beta2-adrenergic receptor in kidney biology: A current prospective[J]. Nephrology, 2019, 24(5): 497-503.
|
| 9 |
Usmani O, Roche N, Marshall J, et al. An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma[J]. Expert Opin Drug Deliv, 2019, 16(12): 1367-1380.
|
| 10 |
夏元旦，杜晓梅，周 敏，等. 吸入型长效抗胆碱能药物及吸入型长效β2受体激动剂在慢性阻塞性肺疾病患者中的应用评价[J]. 药学服务与研究，2019, 19(3): 56-58.
|
| 11 |
Guerreiro I, Soccal PM. COPD and phenotypes[J]. Rev Med Suisse，2019, 15(671): 2082-2086.
|
| 12 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
| 13 |
Perez-Padilla R, Menezes AMB. Chronic obstructive pulmonary disease in latin America[J]. Ann Glob Health, 2019, 85(1): 7-10.
|
| 14 |
Nomura O, Ihara T, Morikawa Y, et al. Metered-dose inhaler ipratropium bromide for children with acute asthma exacerbation: A prospective, non-randomized, observational study[J]. Pediatr Int, 2020, 62(3): 319-323.
|
| 15 |
Derinoz-Guleryuz O, Fidanci I, Men-Atmaca Y. Nebulized ipratropium bromide-induced anisocoria: Why is anisocoria observed[J]. Iran J Allergy Asthma Immunol, 2021, 20(1): 125-128.
|
| 16 |
Pereira Filho FA, Sarni ROS, Wandalsen NF. Evaluation of treatment of the exacerbation of asthma and wheezing in a pediatric emergency department[J]. Rev Assoc Med Bras, 2020, 66(9): 1270-1276.
|
| 17 |
姚萍丽，嵇利芳. 孟鲁司特钠联合复方异丙托溴铵治疗老年支气管哮喘急性发作患者的疗效及对肺功能和炎症因子的影响[J]. 中国老年学杂志，2020, 40(11): 80-82.
|
| 18 |
Samarakoon R, Higgins SP, Higgins CE, et al. The TGF-β1/p53/PAI-1 signaling axis in vascular senescence: Role of caveolin-1[J]. Biomolecules, 2019, 9(8): 341-345.
|
| 19 |
Jin J, Togo S, Kadoya K, et al. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1[J]. Respir Res, 2019, 20(1): 119-122.
|
| 20 |
Ren S, Chen J, Wang Q, et al. MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis[J]. Hepatol Int, 2019, 13(6): 814-825.
|
| 21 |
Wu M, Tong X, Wang D, et al. Soluble intercellular cell adhesion molecule-1 in lung cancer: A meta-analysis[J]. Pathol Res Pract, 2020, 216(10): 1530-1534.
|
| 22 |
Makris S, Venetsanou K, Spartalis E, et al. Changes in serum leptin levels as well as sICAM-1 and sVCAM-1 soluble adhesion molecules during carotid endarterectomy[J]. Eur Rev Med Pharmacol Sci, 2019, 23(5): 2257-2262.
|
| 23 |
Bieuzen F, Hausswirth C, Dugue B. Circulating soluble intercellular adhesion molecule-1 (sICAM-1) after exercise-induced muscular damage: Does the use of whole-body cryostimulation influence its concentration in blood[J]. Cryobiology, 2019, 87(1): 120-122.
|
| 24 |
Strzelczyk JK, Cuber P, Bochon B, et al. The levels of sICAM-1, sELAM-1, TNFα and sTNFR1 proteins in patients with colorectal adenocarcinoma in tumor and corresponding normal mucosa[J]. Acta Biochim Pol, 2020, 67(4): 579-585.
|
| 25 |
Al-Salama ZT, Frampton JE. Glycopyrronium/Formoterol: A eeview in COPD[J]. Drugs, 2019, 79(13): 1455-1466.
|
| 26 |
杨忠民，刘 玻，王 岚，等. 比较固定剂量和递减剂量的ICS联合LABA吸入治疗对慢性阻塞性肺疾病患者生活质量的影响[J]. 临床和实验医学杂志，2019, 18(15): 1617-1621.
|
| 27 |
Singh D, Van den Berg F, Leaker B, et al. Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler[J]. Br J Clin Pharmacol, 2019, 85(4): 729-736.
|